IPA - Key Persons
Job Titles:
- Senior Technical Advisor - Quality and Regulatory
Job Titles:
- Associate
- Secretary General
Job Titles:
- Senior Technical Advisor - Innovation and R & D
Job Titles:
- Member of the Leadership Team
- Managing Director of Panacea Biotec
Dr. Rajesh Jain is Managing Director of Panacea Biotec, a leading Biotechnology Company employing over 2,500 people. He provides strategic leadership, management and guidance to the company. He has extensive experience and qualifications in biotechnology and is responsible for Innovation and Business Development.
Dr. Jain is an active member of major industry associations and government panels. He is a Co-Chair Confederation of Indian Industry (CII), National Committee on Biotechnology for 2017-18. He is a member of Central Drug Research Institute (CDRI), Lucknow. Dr. Jain is a recipient of many awards such as India Innovation Award for 2016 and 2015 by Clarivate Analytics and has been appreciated by GAVI and Bill and Melinda Gates Foundation for his commitment towards making affordable vaccines for population across the globe.
Dr. Jain is a science graduate and holds a PhD in Management. He has authored two position papers for CII: Guideline Changes in Vaccine Approval Procedures and Regulatory & Policy Changes for Sustained Competitiveness of the Indian Vaccine Industry.
Job Titles:
- Member of the Leadership Team
- Managing Director of Zydus Lifesciences Ltd.
Dr. Sharvil Patel is the Managing Director of Zydus Lifesciences Ltd., a global innovation-driven lifesciences company which has a legacy of over 70 years in the field of healthcare. Zydus Lifesciences researches, develops, manufactures and markets wide ranging therapeutics, biologicals and vaccines. Besides this, the group is into high-end diagnostics to detect cancers. Dr. Sharvil Patel also officiates as the Chairman on the Board of Zydus Wellness Ltd., which is creating several novel experiences for the health-conscious consumers and has a basket of niche products and iconic brands. With a specialisation in Chemical and Pharmaceutical Sciences from the University of Sunderland, U.K., and a doctorate also from the same university for his research work in Breast Cancer at Johns Hopkins, Bayview Medical Centre, USA, Dr. Sharvil combines both pharma and research expertise.
Dr. Sharvil Patel's leadership has inspired the organization to explore an expansive canvas of thoughts and ideas which are patient-centric, innovative and futuristic. With a turnover of over Rs. 17000 crores ($2.15 bn), Zydus today has a global presence in over 55 countries worldwide. In the US, the group has been contributing to health and well-being since the last 21 years. The group's subsidiary, Zydus Pharmaceuticals USA Inc., is based at Pennington, New Jersey, USA. Zydus' operations in the US are focused on affordable generics, specialty drugs for rare and orphan diseases and the animal health spectrum. The US business contributes to nearly 45% of the group's revenues.
Dr. Sharvil Patel has been conferred the ET Pharmaleader of the year at the ET Healthworld India Pharma Awards 2022. He has also been conferred the ‘The Economic Times Most Promising Business Leaders of Asia 2020-21' Award,' GenNext Entrepreneur of the Forbes India Leadership Awards (FILA) 2020-21' by the Forbes India and ‘Young Turks Award' by India Pharma Awards 2021. He received the ‘40 Under 40 Most Influential Asians' Award by the Asian Business & Social Forum 2018 (ABSF) and the Young Business Leader '40 under Forty' Award by ET Now in 2017.
Job Titles:
- Associate ( Strategic Projects Manager )
Job Titles:
- Executive Assistant Cum Admin Head
Job Titles:
- Member of the Leadership Team
- Chairman of the Ahmedabad
Mr Samir Mehta is the Chairman of the Ahmedabad-based multinational conglomerate Torrent Group. An experienced strategic leader, he has helped Torrent Pharma drive several strategic transformations including forays into new therapies and geographies, large investments in product development infrastructure and capabilities, and building state-of-the-art manufacturing facilities and acquisitions.
His operational excellence and efficiency have helped Torrent Pharma become one of India's fast-growing and trusted pharmaceutical companies. His emphasis on professional organisational design, precise execution and operational efficiencies has built a strong and globally competitive generic business platform in Torrent Pharma.
With a lifelong commitment to improving human health, Mr Mehta has constantly strived for the social empowerment and upliftment of the underprivileged class. He has been instrumental in bringing a culture of change within Torrent Pharma and helped establish an employee-centric workplace promoting equality and fairness at all levels.
A passionate leader, Mr Mehta is committed to global health priorities and increasing accessibility for patients across the globe
Job Titles:
- Senior Technical Advisor - Quality, Regulatory & Manufacturing
Job Titles:
- Member of the Leadership Team
- Secretary
- Secretary General
Mr Sudarshan Jain, is the Secretary-General of the Indian Pharmaceutical Alliance, Advisor - APAX Partners and Board member of multiple organisations. Known for his strong passion for healthcare and the education sector, he has served in multiple leadership positions for over 40 years in the Healthcare industry (Lupin, Johnson & Johnson, Piramal, Abbott) and was formerly the Managing Director at Abbott Healthcare Solutions.
Mr Jain's current Board engagements include Abbott India, Healthium Limited (Apax portfolio company), Zandu Chemicals Limited, Indian Institute of Health Management Research - Jaipur, Indian Education Society (IES), Advisory Board of Narsee Monjee University, Mumbai (NMIMS). He is the Visiting Faculty at the Indian Institute of Management (IIM), Ahmedabad. He has contributed to shaping the healthcare policy and improving access to healthcare in India.
He is an Alumnus of St. Stephens College, Delhi University and the Indian Institute of Management (IIM), Ahmedabad.
Job Titles:
- Chairman
- Member of the Leadership Team
Satish Reddy is the Chairman of Dr. Reddy's Laboratories. He joined the company in 1993 as Executive Director and since has held positions of increasing responsibility, as Managing Director in 1997 and Vice-Chairman and Managing Director in 2013. Mr. Reddy led the organization's transition from a uni-focused manufacturer of Active Pharmaceutical Ingredients (APIs) to a company that moved up the value chain, with a diverse portfolio of Finished Dosage Formulations, establishing a strong footprint for Dr. Reddy's products across the globe.
Mr. Satish Reddy drives the organization's corporate social responsibility initiatives and is also Chairman of the Dr. Reddy's Foundation. He is an active member of major industry associations and governmental panels including the Indian Pharmaceutical Alliance. He also chairs the Board of Governors of NIPER Hyderabad and is passionate about building NIPER into a world class institute to develop talent for the pharma industry.
Mr. Reddy is passionate about enabling access to affordable healthcare and plays a key role in shaping policies concerning the healthcare sector as well as the economy.
Job Titles:
- Associate Secretary General - Regulatory Affairs
Job Titles:
- Executive Vice - Chairperson
- Member of the Leadership Team
Representing the third generation of Cipla's founding family, Ms Samina Hamied is the Executive Vice-Chairperson of the Company. Samina is an MSc in International Accounting and Finance from the London School of Economics and Political Science.
She worked in the UK and the US with leading global firm Goldman Sachs before joining the Cipla leadership team in 2011.
In 2013, she was designated as "Head Strategic Projects - Cipla New Ventures". She was appointed as an Executive Director of the Company in 2015 and elevated as the Executive Vice-Chairperson of the Company, in 2016. She has been instrumental in driving the Company's current transformation agenda.
Ms Samina has played a key role in successfully incubating and shaping Cipla Health Limited, and spearheading Cipla's ambitious foray into the US market with strategic acquisitions. She has built a top-class leadership pipeline for the Company as it continues to spread its wings globally.